Abbott Fights $3.5M Verdict In GSK Suit Over Norvir
Abbott Laboratories sought Friday to overturn a $3.5 million jury verdict in a dispute with GlaxoSmithKline PLC over a licensing deal for Norvir, having already fought off GSK's antitrust challenge over...To view the full article, register now.
Already a subscriber? Click here to view full article